DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
37 hedge funds and large institutions have $65.1M invested in Dicerna Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+1
Holders Change %
+2.78%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
9
Increased
8
Reduced
10
Closed
8
Calls
$31K
Puts
–
Net Calls
+$31K
Net Calls Change
+$31K
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$3.54M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
$5.51M |
| 3 |
Goldman Sachs
New York
|
$606K |
| 4 |
MC
Matisse Capital
Portland,
Oregon
|
$575K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$2.51M |
